Faslodex (fulvestrant), a new drug for metastatic breast cancer
June 2002
You'll start hearing about Faslodex (fulvestrant), a new drug for metastatic breast cancer.
It's for postmenopausal women whose cancer progresses on tamoxifen or another antiestrogen.
In these women, Faslodex delays tumor progression at least as well as the aromatase inhibitor Arimidex (anastrozole).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote